Vulnerability of women in southern Africa to infection with HIV: Biological determinants and priority health sector interventions

AIDS

Volumn 22, Issue SUPPL. 4, 2008, Pages

  Chersich, Matthew F ^a   Rees, Helen V ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Reproductive Health and HIV Research Unit   (South Africa)

Author keywords

Biological factors; Hiv prevention; Primary prevention; Safe sex; Sexual behaviour; Women's health

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANTIVIRUS AGENT; CONTRACEPTIVE AGENT; ESTROGEN; PROGESTERONE; SEROTONIN;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; CIRCUMCISION; CLINICAL FEATURE; CONDOM; DISEASE PREDISPOSITION; DISEASE SEVERITY; ESTROGEN BLOOD LEVEL; GENITAL HERPES; GENITAL SYSTEM; GEOGRAPHIC DISTRIBUTION; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFECTION PREVENTION; INFECTION RISK; PATIENT COUNSELING; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL EDUCATION; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA; TRICHOMONIASIS; VAGINITIS; VIRUS LOAD;

EID: 58149114613     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000341775.94123.75     Document Type: Review

References (160)

1. UNAIDS, WHO. AIDS epidemic update: December 2007. Available at: http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf. Accessed: August 2008.
2. Chen L, Jha P, Stirling B, Sgaier SK, Daid T, Kaul R, Nagelkerke N. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. PLoS ONE 2007; 2:e1001.
3. Steen R, Dallabetta G. Sexually transmitted infection control with sex workers: regular screening and presumptive treatment augment efforts to reduce risk and vulnerability. Reprod Health Matters 2003; 11:74-90.
4. Lurie MN, Williams BG, Zuma K, Mkaya-Mwamburi D, Garnett GP, Sweat MD, et al. Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS 2003; 17:2245-2252.
5. O'Brien TR, Busch MP, Donegan E, Ward JW, Wong L, Samson SM, et al. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr 1994; 7:705-710.
6. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 1992; 304:809-813.
7. Nicolosi A, Correa Leite ML, Musicco M, Arici C, Gavazzeni G, Lazzarin A. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology 1994; 5:570-575.
8. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409.
9. Seidlin M, Vogler M, Lee E, Lee YS, Dubin N. Heterosexual transmission of HIV in a cohort of couples in New York City. AIDS 1993; 7:1247-1254.
10. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
11. Pilcher CD, Joaki G, Hoffman IF, Martinson FE, Mapanje C, Stewart PW, et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007; 21:1723-1730.
12. Cohen MS, Pilcher CD. Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis 2005; 191:1391-1393.
13. Pilcher CD, Tien HC, Eron JJ Jr, Vernazza PL, Leu SY, Stewart PW, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004; 189: 1785-1792.
14. Motloung T, Myers M, Venter F, Delany S, Rees H, Stevens W. Identifying acute HIV infection - a major new public health challenge. S Afr Med J 2004; 94:531.
15. Halperin DT, Epstein H. Concurrent sexual partnerships help to explain Africa's high HIV prevalence: implications for prevention. Lancet 2004; 364:4-6.
16. Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS 1997; 11:641-648.
17. Helleringer S, Kohler HP. Sexual network structure and the spread of HIV in Africa: evidence from Likoma Island, Malawi. AIDS 2007; 21:2323-2332.
18. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994; 331:341-346.
19. Reynolds SJ, Risbud AR, Shepherd ME, Rompalo AM, Ghate MV, Godbole SV, et al. High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India. Sex Transm Infect 2006; 82:121-126.
20. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
21. WHO, UNAIDS. Consultation on STI interventions for preventing HIV: appraisal of the evidence. Geneva: World Health Organization; 2007.
22. Global HIV Prevention Working Group. Bringing HIV prevention to scale: an urgent global priority. 2007. Available at: www.GlobalHIVPrevention.org.
23. Watson-Jones D, Weiss HA, Rusizoka M, Baisley K, Mugeye K, Changalucha J, et al. Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr 2007; 46:631-642.
24. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187:1513-1521.
25. Shepherd ME, Gangakhedkar RR, Sahay S, Reynolds SJ, Ghate MV, Risbud AR, et al. Incident HIV infection among men attending STD clinics in Pune, India: pathways to disparity and interventions to enhance equity. J Health Popul Nutr 2003; 21:251-263.
26. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83.
27. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52.
28. Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-2119.
29. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, Mugeye K, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-1571.
30. Delany S, Mayaud P, Clayton T, Mlaba N, Akpomiemie G, Hira K, et al. Impact of HSV-2 suppressive therapy on genital and plasma HIV-1 RNA in HIV-1 and HSV-2 seropositive women not taking ART: a randomized placebo-controlled trial in Johannesburg, South Africa. Presented at the 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, CA, USA, 25-28 February 2007 [Abstract 154LB].
31. Nagot N, Ouedraogo A, Foulongne V, Konate I, Weiss HA, Vergne L, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-799.
32. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuniga R, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 2007; 196:1500-1508.
33. Baeten JM, Strick LB, Lucchetti A, Whittington WJH, Sanchez J, Coombs RM, et al. Herpes simplex virus suppressive treatment decreases plasma HIV-1 viral load in HSV-2/HIV-1 coinfected women: a randomised, placebo-controlled, cross-over trial. Presented at the 17th International Society for Sexually Transmitted Diseases Research Meeting. Seattle, WA, USA, 29 July-1 August 2007 [Abstract 96].
34. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008; 22:1493-1501.
35. Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, et al. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS 1998; 12:197-203.
36. van de Wijgert JH, Morrison CS, Cornelisse PG, Munjoma M, Moncada J, Awio P, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr 2008; 48:203-210.
37. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-1868.
38. Myer L, Denny L, Telerant R, Souza M, Wright TC Jr, Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 2005; 192:1372-1380.
39. St John E, Mares D, Spear GT. Bacterial vaginosis and host immunity. Curr HIV/AIDS Rep 2007; 4:22-28.
40. Ghys PD, Diallo MO, Ettiegne-Traore V, Satten GA, Anoma CK, Maurice C, et al. Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers. AIDS 2001; 15:1421-1431.
41. Kapiga SH, Sam NE, Bang H, Ni Q, Ao TTH, Kiwelu I, et al. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis 2007; 195:1260-1269.
42. Kleinschmidt I, Rees H, Delany S, Smith D, Dinat N, Nkala B, McIntyre JA. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007; 75:461-467.
43. McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, et al. Infection with trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698-702.
44. Myer L, Denny L, de Souza M, Wright TC Jr, Kuhn L. Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. Am J Epidemiol 2006; 163:552-560.
45. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998; 12:1699-1706.
46. Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008; 197:548-554.
47. Martin HL Jr, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, Jackson DJ, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998; 178:1053-1059.
48. Hester RA, Kennedy SB. Candida infection as a risk factor for HIV transmission. J Womens Health (Larchmt) 2003; 12:487-494.
49. van de Wijgert J, Morrison C, Cornelisse P, Munjoma M, Moncada J, Kaewvichit R, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr 2008; 48:203-210.
50. Measure DHS. Demographic and health surveys. Available at: http://www.measuredhs.com/accesssurveys/. Accessed: August 2008.
51. Hilber AM, Chersich MF, van de Wijgert JH, Rees H, Temmerman M. Vaginal practices, microbicides and HIV: what do we need to know? Sex Transm Infect 2007; 83:505-508.
52. Kunene B, Manzini N, Scorgie F, Chersich MF, Smit J. Prevalence of vaginal practices in KwaZulu-Natal, South Africa: results of a household survey. In: Microbicides 2008 Conference. New Delhi, India, 24-27 February 2008 [Abstract TC 591].
53. Beksinska ME, Rees HV, Kleinschmidt I, McIntyre J. The practice and prevalence of dry sex among men and women in South Africa: a risk factor for sexually transmitted infections? Sex Transm Infect 1999; 75:178-180.
54. van De Wijgert JH, Mason PR, Gwanzura L, Mbizvo MT, Chirenje ZM, Iliff V, et al. Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. J Infect Dis 2000; 181:587-594.
55. Kilmarx PH, Limpakarnjanarat K, Supawitkul S, Korattana S, Young NL, Parekh BS, et al. Mucosal disruption due to use of a widely-distributed commercial vaginal product: potential to facilitate HIV transmission. AIDS 1998; 12:767-773.
56. McClelland RS, Ndinya-Achola JO, Baeten JM. 'Is vaginal washing associated with increased risk of HIV-1 acquisition?' [Correspondence]. AIDS 2006; 20:1347-1348.
57. Hassan WM, Lavreys L, Chohan V, Richardson BA, Mandaliya K, Ndinya-Achola JO, et al. Associations between intravaginal practices and bacterial vaginosis in Kenyan female sex workers without symptoms of vaginal infections. Sex Transm Dis 2007; 34:384-388.
58. Simpson T, Merchant J, Grimley DM, Oh MK. Vaginal douching among adolescent and young women: more challenges than progress. J Pediatr Adolesc Gynecol 2004; 17:249-255.
59. Wilkinson D, Ramjee G, Tholandi M, Rutherford G. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database Syst Rev 2002; CD003939.
60. McClelland RS, Lavreys L, Hassan WM, Mandaliya K, Ndinya-Achola JO, Baeten JM. Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study. AIDS 2006; 20:269-273.
61. Myer L, Denny L, de Souza M, Wright TC Jr, Kuhn L. Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. Am J Epidemiol 2006; 163:552-560.
62. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005; 366:1182-1188.
63. Leroy V, Van de Perre P, Lepage P, Saba J, Nsengumuremyi F, Simonon A, et al. Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS 1994; 8:983-986.
64. Mbizvo MT, Kasule J, Mahomed K, Nathoo K. HIV-1 seroconversion incidence following pregnancy and delivery among women seronegative at recruitment in Harare, Zimbabwe. Cent Afr J Med 2001; 47:115-118.
65. Morrison CS, Wang J, Van Der Pol B, Padian N, Salata RA, Richardson BA. Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe. AIDS 2007; 21:1027-1034.
66. Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, Mandaliya K, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007; 21:1771-1777.
67. Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: a meta-analysis. J Acquir Immune Defic Syndr 1999; 21:51-58.
68. Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21:85-95.
69. Kleinschmidt I, Rees H, Delany S, Smith D, Dinat N, Nkala B, McIntyre JA. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007; 75:461-467.
70. Myer L, Denny L, Wright TC, Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007; 36:166-174.
71. Kiddugavu M, Makumbi F, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 2003; 17:233-240.
72. Jacobson DL, Peralta L, Farmer M, Graham NM, Gaydos C, Zenilman J. Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents. Sex Transm Dis 2000; 27:313-319.
73. Michael CW, Esfahani FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol 1997; 17:99-107.
74. Beagley KW, Gockel CM. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003; 38:13-22.
75. Brabin L. Interactions of the female hormonal environment, susceptibility to viral infections, and disease progression. AIDS Patient Care STDS 2002; 16:211-221.
76. Prakash M, Patterson S, Gotch F, Kapembwa MS. Ex vivo analysis of HIV-1 co-receptors at the endocervical mucosa of women using oral contraceptives. Br J Obstet Gynaecol 2004; 111:1468-1470.
77. Yeaman GR, Guyre PM, Fanger MW, Collins JE, White HD, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 1997; 61:427-435.
78. Myer L, Wright TC Jr, Denny L, Kuhn L. Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex Transm Dis 2006; 33:683-687.
79. Chersich MF, Luchters SM, Yard E, Othigo JM, Kley N, Temmerman M. Morbidity in the first year postpartum among HIV-infected women in Kenya. Int J Gynaecol Obstet 2008; 100:45-51.
80. Myer L, Mathews C, Little F. Condom use and sexual behaviors among individuals procuring free male condoms in South Africa: a prospective study. Sex Transm Dis 2002; 29:239-241.
81. Aklilu M, Messele T, Tsegaye A, Biru T, Mariam DH, van Benthem B, et al. Factors associated with HIV-1 infection among sex workers of Addis Ababa, Ethiopia. AIDS 2001; 15:87-96.
82. Sarkar K, Bal B, Mukherjee R, Saha MK, Chakraborty S, Niyogi SK, Bhattacharya SK. Young age is a risk factor for HIV among female sex workers - an experience from India. J Infect 2006; 53:255-259.
83. Pettifor AE, Hudgens MG, Levandowski BA, Rees HV, Cohen MS. Highly efficient HIV transmission to young women in South Africa. AIDS 2007; 21:861-865.
84. Gopinath R, Ostrowski M, Justement SJ, Fauci AS, Nutman TB. Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. J Infect Dis 2000; 182:1804-1808.
85. Bentwich Z, Maartens G, Torten D, Lal AA, Lal RB. Concurrent infections and HIV pathogenesis. AIDS 2000; 14:2071-2081.
86. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, Hotez PJ. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006; 367:1521-1532.
87. Borkow G, Bentwich Z. HIV and helminth co-infection: is deworming necessary? Parasite Immunol 2006; 28:605-612.
88. Fauci AS. Pathogenesis of HIV disease: opportunities for new prevention interventions. Clin Infect Dis 2007; 45 (Suppl. 4): S206-S212.
89. Hotez P, Stoever K, Fenwick A, Molyneux D, Savioli L. The Lancet's chronic diseases series. Lancet 2006; 367:563-564; author reply 564-565.
90. Hotez PJ, Molyneux DH, Stillwaggon E, Bentwich Z, Kumaresan J. Neglected tropical diseases and HIV/AIDS. Lancet 2006; 368:1865-1866.
91. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298.
92. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656.
93. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666.
94. Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 2006; 3:e262.
95. WHO, UNAIDS. New data on male circumcision and HIV prevention: policy and programme implications. 2007. Available at: http://www.who.int/hiv/ mediacentre/MCrecommendations_en.pdf. Accessed: August 2008.
96. UNAIDS. Male circumcision: global trends and determinants of prevalence, safety and acceptability. 2007. Available at: http://www.who.int/hiv/topics/malecircumcision/ JC1320_MaleCircumcision_Final_UNAIDS.pdf. Accessed: August 2008.
97. UNAIDS. HIV prevention needs and successes: a tale of three countries - an update on HIV prevention success in Senegal, Thailand and Uganda. Geneva: UNAIDS; 2001.
98. UNAIDS. Evidence for HIV decline in Zimbabwe: a comprehensive review of the epidemiological data. Geneva: UNAIDS; 2005.
99. WHO, UNAIDS, UNFPA. Position statement on condoms and HIV prevention. 2004. Available at: http://www.who.int/reproductive-health/stis/docs/ condom_statement04.pdf. Accessed: August 2008.
100. Balaji A, Lowry R, Brener N, Kann L, Romero R, Wechsler H. Trends in HIV- and STD-related risk behaviors among high school students - United States, 1991-2007. MMWR Morb Mortal Wkly Rep 2008; 57:817-822.
101. Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001; 358:1835-1842.
102. Pettifor AE, Rees HV, Kleinschmidt I, Steffenson AE, MacPhail C, Hlongwa-Madikizela L, et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS 2005; 19:1525-1534.
103. Snelling D, Rasugu Omariba DW, Hong S, Georgiades K, Racine Y, Boyle MH. HIV/AIDS knowledge, women's education, epidemic severity and protective sexual behaviour in low- and middle-income countries. J Biosoc Sci 2007; 39:421-442.
104. Mah TL, Halperin DT. Concurrent sexual partnerships and the HIV epidemics in Africa: evidence to move forward. AIDS Behav 2008; [Epub ahead of print].
105. Mabey D, Mayaud P. Sexually transmitted diseases in mobile populations. Genitourin Med 1997; 73:18-22.
106. Mbizvo MT, Machekano R, McFarland W, Ray S, Bassett M, Latif A, Katzenstein D. HIV seroincidence and correlates of seroconversion in a cohort of male factory workers in Harare, Zimbabwe. AIDS 1996; 10:895-901.
107. Shisana O, Rehle T, Simbayi L, Parker W, Zuma K, Bhana A, et al. South African National HIV Prevalence, HIV Incidence, Behaviour and Communication Survey. Cape Town: HSRC Press; 2005. Available at: http://www.hsrcpress.ac.za/product.php?productid=2134&freedownload=1
108. Maharaj P, Cleland J. Risk perception and condom use among married or cohabiting couples in KwaZulu-Natal, South Africa. Int Fam Plan Perspect 2005; 31:24-29.
109. Prata N, Morris L, Mazive E, Vahidnia F, Stehr M. Relationship between HIV risk perception and condom use: evidence from a population-based survey in Mozambique. Int Fam Plan Perspect 2006; 32:192-200.
110. Lane T, Pettifor A, Pascoe S, Fiamma A, Rees H. Heterosexual anal intercourse increases risk of HIV infection among young South African men. AIDS 2006; 20:123-125.
111. Simbayi LC, Kalichman SC, Jooste S, Cherry C, Mfecane S, Cain D. Risk factors for HIV-AIDS among youth in Cape Town, South Africa. AIDS Behav 2005; 9:53-61.
112. Karim SS, Ramjee G. Anal sex and HIV transmission in women. Am J Public Health 1998; 88:1265-1266.
113. Stadler JJ, Delany S, Mntambo M. Sexual coercion and sexual desire: ambivalent meanings of heterosexual anal sex in Soweto, South Africa. AIDS Care 2007; 19:1189-1193.
114. Ndinda C, Chimbwete C, McGrath N, Pool R. Perceptions of anal sex in rural South Africa. Cult Health Sex 2008; 10:205-212.
115. Kalichman SC, Simbayi LC, Cain D, Cherry C, Jooste S. Coital bleeding and HIV risks among men and women in Cape Town, South Africa. Sex Transm Dis 2006; 33:551-557.
116. Tanfer K, Aral SO. Sexual intercourse during menstruation and self-reported sexually transmitted disease history among women. Sex Transm Dis 1996; 23:395-401.
117. Kalichman SC, Simbayi LC. Sexual exposure to blood and increased risks for heterosexual HIV transmission in Cape Town, South Africa. Afr J Reprod Health 2004; 8:55-58.
118. Campo J, Perea MA, del Romero J, Cano J, Hernando V, Bascones A. Oral transmission of HIV, reality or fiction? An update. Oral Dis 2006; 12:219-228.
119. del Romero J, Marincovich B, Castilla J, Garcia S, Campo J, Hernando V, Rodriguez C. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 2002; 16:1296-1297.
120. Scully C, Porter S. HIV topic update: oro-genital transmission of HIV. Oral Dis 2000; 6:92-98.
121. Rehm J, Gmel G, Room R, Frick U. Average volume of alcohol consumption, drinking patterns and related burden of mortality in young people in established market economies of Europe. Eur Addict Res 2001; 7:148-151.
122. Rehm J, Room R, Graham K, Monteiro M, Gmel G, Sempos CT. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction 2003; 98:1209-1228.
123. World Health Organization. Surveys of drinking patterns and problems in seven developing countries. WHO monograph on alcohol epidemiology in developing countries. Geneva: WHO; 2000.
124. Rehm J, Rehn N, Room R, Monteiro M, Gmel G, Jernigan D, Frick U. The global distribution of average volume of alcohol consumption and patterns of drinking. Eur Addict Res 2003; 9:147-156.
125. Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis 2007; 34:856-863.
126. Fisher JC, Cook PA, Sam NE, Kapiga SH. Patterns of alcohol use, problem drinking, and HIV infection among high-risk African women. Sex Transm Dis 2008; 35:537-544.
127. Chersich MF, Luchters SMF, Malonza IM, Mwarogo P, King'ola N, Temmerman M. Heavy episodic drinking among Kenyan female sex workers is associated with unsafe sex, sexual violence and sexually transmitted infections. Int J STD AIDS 2007; 18:764-769.
128. Graham K, West P, Wells S. Evaluating theories of alcohol-related aggression using observations of young adults in bars. Addiction 2000; 95:847-863.
129. Pihl RO, Peterson JB, Lau MA. A biosocial model of the alcohol-aggression relationship. J Stud Alcohol Suppl 1993; 11:128-139.
130. Parsons JT, Vicioso K, Kutnick A, Punzalan JC, Halkitis PN, Velasquez MM. Alcohol use and stigmatized sexual practices of HIV seropositive gay and bisexual men. Addict Behav 2004; 29:1045-1051.
131. Lugalla J, Emmelin M, Mutembei A, Sima M, Kwesigabo G, Killewo J, Dahlgren L. Social, cultural and sexual behavioral determinants of observed decline in HIV infection trends: lessons from the Kagera Region, Tanzania. Soc Sci Med 2004; 59:185-198.
132. Chisholm D, Rehm J, Van Ommeren M, Monteiro M. Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. J Stud Alcohol 2004; 65:782-793.
133. 61st World Health Assembly. Strategies to reduce the harmful use of alcohol: report by the Secretariat. 2008. Available at: http://www.who.int/ gb/ebwha/pdf_files/A61/A61_13-en.pdf. Accessed: August 2008.
134. World Health Organization. Brief intervention for hazardous and harmful drinking. A manual for use in primary care. Geneva: WHO; 2001.
135. WHO, ILO. Joint WHO/ILO guidelines on post-exposure prophylaxis (PEP) to prevent HIV infection. 2007. Available at: http://whqlibdoc.who.int/ publications/2007/9789241596374_eng.pdf. Accessed: August 2008.
136. Chesson HW. Cost effectiveness of one to one STI prevention interventions. Sex Transm Infect 2007; 83:423-424.
137. Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA 1998; 280:1161-1167.
138. Chersich M, Temmerman M. Increasing access to HIV testing for women by simplifying pre- and post-test counselling. Curr Women's Health Rev 2008; in press.
139. World Health Organization. Reproductive health matters for the World Health Organisation. Beyond acceptability: users' perspectives on contraception. Geneva: WHO; 1997.
140. Thomsen SC, Ombidi W, Toroitich-Ruto C, Wong EL, Tucker HO, Homan R, et al. A prospective study assessing the effects of introducing the female condom in a sex worker population in Mombasa, Kenya. Sex Transm Infect 2006; 82:397-402.
141. Vijayakumar G, Mabude Z, Smit J, Beksinska M, Lurie M. A review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence. Int J STD AIDS 2006; 17:652-659.
142. De Cock KM, Marum E, Mbori-Ngacha D. A serostatus-based approach to HIV/AIDS prevention and care in Africa. Lancet 2003; 362:1847-1849.
143. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, De Cock KM. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health 2001; 91:1019-1024.
144. Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet 2004; 364:41-50.
145. WHO, PEPFAR, UNAIDS. Task shifting: rational redistribution of tasks among health workforce teams. Global recommendations and guidelines. Geneva: WHO; 2008.
146. Gregson S, Adamson S, Papaya S, Mundondo J, Nyamukapa CA, Mason PR, et al. Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe. PLoS Med 2007; 4:e102.
147. Grosskurth H, Mosha F, Todd J, Senkoro K, Newell J, Klokke A, et al. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results. AIDS 1995; 9:927-934.
148. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 2003; 361:645-652.
149. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 2004; 291:2555-2562.
150. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999; 353:525-535.
151. Orroth KK, White RG, Korenromp EL, Bakker R, Changalucha J, Habbema JD, Hayes RJ. Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: simulation results. Sex Transm Dis 2006; 33:536-544.
152. Voeten HA, O'Hara HB, Kusimba J, Otido JM, Ndinya-Achola JO, Bwayo JJ, et al. Gender differences in health care-seeking behavior for sexually transmitted diseases: a population-based study in Nairobi, Kenya. Sex Transm Dis 2004; 31:265-272.
153. Paz-Bailey G, Rahman M, Chen C, Ballard R, Moffat HJ, Kenyon T, et al. Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease. Clin infect Dis 2005; 41:1304-1312.
154. Krishnan S, Dunbar MS, Minnis AM, Medlin CA, Gerdts CE, Padian NS. Poverty, gender inequities and women's risk of HIV/AIDS. Ann NY Acad Sci 2008; 1136:101-110.
155. Dunkle KL, Jewkes R, Nduna M, Jama N, Levin J, Sikweyiya Y, Koss MP. Transactional sex with casual and main partners among young South African men in the rural Eastern Cape: prevalence, predictors, and associations with gender-based violence. Soc Sci Med 2007; 65:1235-1248.
156. Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection. Soc Sci Med 2004; 59:1581-1592.
157. Wojcicki JM. She drank his money": survival sex and the problem of violence in taverns in Gauteng province, South Africa. Med Anthropol Q 2002; 16:267-293.
158. Chersich MF, Luchters SM, Othigo MJ, Yard E, Mandaliya K, Temmerman M. HIV testing and counselling for women attending child health clinics: an opportunity for entry to prevent mother-to-child transmission and HIV treatment. Int J STD AIDS 2008; 19:42-46.
159. Crosby RA, Holtgrave DR. The protective value of social capital against teen pregnancy: a state-level analysis. J Adolesc Health 2006; 38:556-559.
160. Holtgrave DR, Crosby RA. Social capital, poverty, and income inequality as predictors of gonorrhoea, syphilis, chlamydia and AIDS case rates in the United States. Sex Transm Infect 2003; 79:62-64.